Office of the Director, National Institutes of Health; Notice of Meeting, 67096-67097 [2024-18481]

Download as PDF 67096 Federal Register / Vol. 89, No. 160 / Monday, August 19, 2024 / Notices Consent/Consent Documentation, OMB No. 0990–0260. Information reported to the Federal departments and agencies under the Common Rule with respect to a satisfactory assurance is used to ensure that an institution engaged in nonexempt research involving human subjects conducted or supported by a Common Rule department or agency has (1) established adequate administrative policies and procedures for protecting the rights and welfare of human subjects in research, and (2) accepts that responsibility. Other reporting requirements are used to: assess whether the institution is following the established procedures; ensure that Federal funds are not expended for unapproved human subjects research; and, determine if the approved status of an awarded grant, contract, or cooperative agreement should be reviewed, with the ultimate goal of maintaining or increasing human subject protections. Likely Respondents: Institutions and institutional review boards. Annualized Burden Hour Tables TABLE 1—ESTIMATED ANNUAL IRB RECORDKEEPING BURDEN Number of respondents Common rule provision Number of responses per respondent Total annual responses Average burden per response Total hours .115 [Pre-2018 and 2018 Requirement]—Preparation and documentation of IRB activities ........................................ 6,000 16 96,000 12 1,152,000 Total .............................................................................. ........................ ........................ 96,000 ........................ 1,152,000 TABLE 2—ESTIMATED ANNUAL THIRD-PARTY DISCLOSURE BURDEN Number of respondents .109(d) [Pre-2018 and 2018 Requirements]—Written notification of IRB approval or disapproval of research .......... .116(a) and (b) (Pre-2018 Requirements)/.116 (b), (c) and (d) [2018 Requirements]—Elements of informed consent and broad consent ........................................................... .116(h)—[2018 Requirements]—Posting clinical trial consent form .......................................................................... .117(a) [Pre-2018 and 2018 Requirements]—Documentation of informed consent ................................................... .117(c)(2) [Pre-2018 and 2018 Requirements]—Written statement about the research when informed consent documentation is waived .................................................. Total .............................................................................. Sherrette A. Funn, Paperwork Reduction Act Reports Clearance Officer, Office of the Secretary. Number of disclosures per respondent Total annual disclosures 25 150,000 0.5 75,000 6,000 25 150,000 0.5 75,000 425 5 2,125 0.5 1,063 6,000 20 120,000 0.5 60,000 6,000 5 30,000 .5 15,000 ........................ ........................ 452,125 ........................ 226,063 [FR Doc. 2024–18447 Filed 8–16–24; 8:45 am] BILLING CODE 4150–36–P [FR Doc. 2024–18489 Filed 8–16–24; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health ddrumheller on DSK120RN23PROD with NOTICES1 National Library of Medicine; Amended Notice of Meeting Notice is hereby given of a change in the meeting of the National Library of Medicine Board of Scientific Counselors, November 7, 2024, 11:00 a.m. to 2:30 p.m., which was published in the Federal Register on July 15, 2024, 89 FR 135, Page Number 57422. This notice is being amended to announce that the meeting date will be changed from November 7, 2024, to November 6, 2024. The meeting will be virtual. VerDate Sep<11>2014 18:07 Aug 16, 2024 Jkt 262001 National Institutes of Health Office of the Director, National Institutes of Health; Notice of Meeting Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of a meeting of the Advisory Committee on Research on Women’s Health. The meeting will be open to the public as a virtual meeting. Individuals who plan to view the virtual meeting and need special assistance or other reasonable accommodations to view the meeting, should notify the Contact PO 00000 Total hours 6,000 Dated: August 13, 2024. Miguelina Perez, Program Analyst, Office of Federal Advisory Committee Policy. DEPARTMENT OF HEALTH AND HUMAN SERVICES Average burden per disclosure Frm 00040 Fmt 4703 Sfmt 4703 Person listed below in advance of the meeting. The meeting will be videocast and can be accessed from the NIH Videocasting and Podcasting website (https://videocast.nih.gov/). Name of Committee: Advisory Committee on Research on Women’s Health. Date: October 8, 2024. Time: 9:00 a.m. to 4:30 p.m. Agenda: ORWH Director’s Report, Presentation from NIBIB and SEED Office Directors, Panel discussion on technology, engineering and, innovation in women’s health, presentation from the U.S. National Science Foundation’s Directorate for Engineering Director, presentations of concepts for Advisory Committee clearance including Funding Opportunities to Support Research on Chronic Female-Specific and Gynecologic Conditions and Careers of Women. Place: National Institutes of Health, 9000 Rockville Pike, Building 31, Bethesda, MD 20892 (In-Person and Virtual Meeting). Contact Person: Vivian Ota Wang, Ph.D., FACMG, CGC, Deputy Director, Office on Research for Women’s Health, Division of Program Coordination, Planning and E:\FR\FM\19AUN1.SGM 19AUN1 Federal Register / Vol. 89, No. 160 / Monday, August 19, 2024 / Notices Strategic Initiatives, National Institutes of Health, 6707 Democracy Blvd., Bethesda, MD 20892, 240–550–9892, otawangv@nih.gov. Any member of the public interested in presenting oral comments to the committee may notify the Contact Person listed on this notice at least 10 days in advance of the meetings. Interested individuals and representatives of organizations may submit a letter of intent, a brief description of the organization represented, and a short description of the oral presentation. Only one representative of an organization may be allowed to present oral comments and if accepted by the committee, presentations may be limited to five minutes. Both printed and electronic copies are requested for the record. In addition, any interested person may file written comments with the committee by forwarding their statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. Information is also available on the Institute’s/Center’s home page: https:// orwh.od.nih.gov/, where an agenda and any additional information for the meeting will be posted when available. (Catalogue of Federal Domestic Assistance Program Nos. 93.14, Intramural Research Training Award; 93.22, Clinical Research Loan Repayment Program for Individuals from Disadvantaged Backgrounds; 93.232, Loan Repayment Program for Research Generally; 93.39, Academic Research Enhancement Award; 93.936, NIH Acquired Immunodeficiency Syndrome Research Loan Repayment Program; 93.187, Undergraduate Scholarship Program for Individuals from Disadvantaged Backgrounds, National Institutes of Health, HHS) Dated: August 13, 2024. Miguelina Perez, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2024–18481 Filed 8–16–24; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health ddrumheller on DSK120RN23PROD with NOTICES1 National Institute on Aging; Notice of Closed Meeting Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant VerDate Sep<11>2014 18:07 Aug 16, 2024 Jkt 262001 67097 applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. (Catalogue of Federal Domestic Assistance Program Nos. 93.866, Aging Research, National Institutes of Health, HHS) Name of Committee: National Institute on Aging Initial Review Group; Career Development for Established Investigators and Conference Grants Study Section. Date: October 10–11, 2024. Time: 10:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institute on Aging, 5601 Fishers Ln, Rockville, MD 20852 (Virtual Meeting). Contact Person: Rajasri Roy, Ph.D., Scientific Review Officer, Scientific Review Branch, National Institute on Aging, 5601 Fishers Lane, Rm 2W200, Rockville, MD 20852, 301–496–6477, rajasri.roy@nih.gov. Dated: August 5, 2024. Miguelina Perez, Program Analyst, Office of Federal Advisory Committee Policy. (Catalogue of Federal Domestic Assistance Program Nos. 93.866, Aging Research, National Institutes of Health, HHS) Dated: August 13, 2024. Miguelina Perez, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2024–18487 Filed 8–16–24; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute on Aging; Notice of Closed Meeting Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute on Aging Special Emphasis Panel; Brain Cell Atlas of AD/ADRD. Date: September 17, 2024. Time: 11:00 a.m. to 3:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institute on Aging, 5601 Fishers Ln, Rockville, MD 20852 (Virtual Meeting). Contact Person: Sandhya Sanghi, Ph.D., Scientific Review Officer, National Institute of Aging, National Institute of Health, 7201 Wisconsin Ave., Bethesda, MD 20814, (301) 496–2879, sandhya.sanghi@nih.gov. PO 00000 Frm 00041 Fmt 4703 Sfmt 9990 [FR Doc. 2024–18486 Filed 8–16–24; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meeting Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel; CLINICAL TRIAL ON ACHALASIA. Date: September 24, 2024. Time: 2:00 p.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, NIDDK, Democracy II, Suite 7000A, 6707 Democracy Boulevard, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Maria E. Davila-Bloom, Ph.D., Scientific Review Officer, National Institute of Diabetes and Digestive and Kidney, National Institute of Health, 6707 Democracy Blvd., Rm 7017, Bethesda, MD 20892–5452, (301) 594–7637, davilabloomm@extra.niddk.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.847, Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology and Hematology Research, National Institutes of Health, HHS) Dated: August 13, 2024. Miguelina Perez, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2024–18485 Filed 8–16–24; 8:45 am] BILLING CODE 4140–01–P E:\FR\FM\19AUN1.SGM 19AUN1

Agencies

[Federal Register Volume 89, Number 160 (Monday, August 19, 2024)]
[Notices]
[Pages 67096-67097]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-18481]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Office of the Director, National Institutes of Health; Notice of 
Meeting

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of a meeting of the Advisory Committee 
on Research on Women's Health.
    The meeting will be open to the public as a virtual meeting. 
Individuals who plan to view the virtual meeting and need special 
assistance or other reasonable accommodations to view the meeting, 
should notify the Contact Person listed below in advance of the 
meeting. The meeting will be videocast and can be accessed from the NIH 
Videocasting and Podcasting website (https://videocast.nih.gov/).

    Name of Committee: Advisory Committee on Research on Women's 
Health.
    Date: October 8, 2024.
    Time: 9:00 a.m. to 4:30 p.m.
    Agenda: ORWH Director's Report, Presentation from NIBIB and SEED 
Office Directors, Panel discussion on technology, engineering and, 
innovation in women's health, presentation from the U.S. National 
Science Foundation's Directorate for Engineering Director, 
presentations of concepts for Advisory Committee clearance including 
Funding Opportunities to Support Research on Chronic Female-Specific 
and Gynecologic Conditions and Careers of Women.
    Place: National Institutes of Health, 9000 Rockville Pike, 
Building 31, Bethesda, MD 20892 (In-Person and Virtual Meeting).
    Contact Person: Vivian Ota Wang, Ph.D., FACMG, CGC, Deputy 
Director, Office on Research for Women's Health, Division of Program 
Coordination, Planning and

[[Page 67097]]

Strategic Initiatives, National Institutes of Health, 6707 Democracy 
Blvd., Bethesda, MD 20892, 240-550-9892, [email protected].

    Any member of the public interested in presenting oral comments 
to the committee may notify the Contact Person listed on this notice 
at least 10 days in advance of the meetings. Interested individuals 
and representatives of organizations may submit a letter of intent, 
a brief description of the organization represented, and a short 
description of the oral presentation. Only one representative of an 
organization may be allowed to present oral comments and if accepted 
by the committee, presentations may be limited to five minutes. Both 
printed and electronic copies are requested for the record. In 
addition, any interested person may file written comments with the 
committee by forwarding their statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.
    Information is also available on the Institute's/Center's home 
page: https://orwh.od.nih.gov/, where an agenda and any additional 
information for the meeting will be posted when available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.14, 
Intramural Research Training Award; 93.22, Clinical Research Loan 
Repayment Program for Individuals from Disadvantaged Backgrounds; 
93.232, Loan Repayment Program for Research Generally; 93.39, 
Academic Research Enhancement Award; 93.936, NIH Acquired 
Immunodeficiency Syndrome Research Loan Repayment Program; 93.187, 
Undergraduate Scholarship Program for Individuals from Disadvantaged 
Backgrounds, National Institutes of Health, HHS)

    Dated: August 13, 2024.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-18481 Filed 8-16-24; 8:45 am]
BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.